An oral and injectable composition for mammals comprising a salt of glucosamine, such as glucosamine hydrochloride, sulfate, nitrate, or iodide, a chondroitin sulfate, hydrolyzed or native collagen, a sodium hyaluronate, chelated manganese ascorbate, and L-malic acid in powder form for oral ingestion or in a solution of sterilized water for injection. The composition acts as a chondroprotective agent which provides foundational support for the creation of new body tissue and cartilage growth in humans and animals. Other beneficial physiological properties include the enhancement of chondrocyte synthesis, the healing of chronic or acute wounds, the maintenance of healthy muscle and tissue, increasing the desirable concentration of hyaluronic acid, and anti-inflammatory activity.

Oral and injectable nutritional composition

The invention relates to compositions containing selenite-containing compounds and pharmaceutically acceptable acids, selected from citric acid, acetic acid, malic acid, carbonic acid, sulphuric acid, nitric acid, hydrochloric acid, fruit acids or mixtures thereof, for use for treating cervical inflammations, dysplasia and/or carcinomas. The invention further relates to methods of using such compositions.

Fuchs; Norbert

SELO MEDICAL GMBH

Pharmaceutical preparation containing selenite or selenite-containing compounds for treating cervical dysplasia or carcinomas

Chemically stable dithranol compositions useful as topical treatment for inflammatory disorders such as psoriasis, eczema and seborrheic dermatitis are disclosed. Incorporation of a certain alpha hydroxyacid as its free acid, lactone, amide or salt form in dithranol containing compositions has been found to chemically stabilize said compositions. The alpha hydroxyacids include glyceric acid, gluconic acid, galacturonic acid, glucuronic acid, glucoheptonic acid, galactonic acid, malic acid, mucic acid, citric acid, saccharic acid, tartaric acid, tartronic acid, isocitric acid and glucuronamide. A single member of the above alpha hydroxyacids may be present in a total amount of from 0.01 to 1 percent by weight of the total composition, or a plurality thereof may be present in a preferred concentration range of from 0.02 to 0.5 percent by weight of the total composition.

malic acid/inflamação

Oral and injectable nutritional composition

Pharmaceutical preparation containing selenite or selenite-containing compounds for treating cervical dysplasia or carcinomas

Pharmaceutical preparation containing selenite or selenite-containing compounds for treating cervical dysplasia or carcinomas

Dithranol compositions stabilized with alpha hydroxyacids

O mais completo banco de dados de ervas medicinais apoiado pela ciência